Literature DB >> 1644547

Magnetic resonance velocity measurements in small arteries. Comparison with Doppler ultrasonic measurements in the aortas of normal rabbits.

R E Wendt1, R Rokey, W F Wong, A Marks.   

Abstract

RATIONALE AND
OBJECTIVES: Magnetic resonance imaging (MRI) can be used to measure motion. This study compares MRI blood flow velocity measurements to Doppler ultrasound velocity measurements in an animal model.
MATERIALS AND METHODS: Blood flow in the abdominal aortas of nine normal rabbits was measured using 16-frame, velocity-resolved MRI and Doppler ultrasound. The MRI data were processed into velocity spectra to aid in their interpretation.
RESULTS: Maximum velocity measurements made by range-gated Doppler ultrasound were predicted by the maximum velocity values derived from MR velocity spectra with a slope of 0.861, an intercept of -2.78 cm/second, and an R-value of 0.935 in 70 measurements.
CONCLUSIONS: Despite the longer time required for the MR measurement, the MR velocity measurement may be useful in the assessment of deep vessels or those obscured by other structures, which are difficult to measure with ultrasound.

Entities:  

Mesh:

Year:  1992        PMID: 1644547     DOI: 10.1097/00004424-199207000-00002

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  2 in total

1.  Comparison of blood velocity measurements between ultrasound Doppler and accelerated phase-contrast MR angiography in small arteries with disturbed flow.

Authors:  Jingfeng Jiang; Charles Strother; Kevin Johnson; Sara Baker; Dan Consigny; Oliver Wieben; James Zagzebski
Journal:  Phys Med Biol       Date:  2011-02-23       Impact factor: 3.609

2.  On the optimal temporal resolution for phase contrast cardiovascular magnetic resonance imaging: establishment of baseline values.

Authors:  Francesco Santini; Michele Pansini; Maja Hrabak-Paar; Denise Yates; Thomas H Langenickel; Jens Bremerich; Oliver Bieri; Tilman Schubert
Journal:  J Cardiovasc Magn Reson       Date:  2020-10-05       Impact factor: 5.364

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.